HealthEngine found guilty of misleading conduct

The Federal Court has ordered HealthEngine to pay $2.9 million in penalties for misleading reviews and patient referrals.

HealthEngine, which describes itself as Australia’s largest online health marketplace and used by over a million consumers every month, admitted that between 30 April 2014 and 30 June 2018 it gave non-clinical personal information, such as names, dates of birth, phone numbers, email addresses, of over 135,000 patients to third party private health insurance brokers without adequately disclosing this to consumers.

HealthEngine earned more than $1.8 million from its arrangements with private health insurance brokers during this period.

HealthEngine was also ordered to contact affected consumers and provide details of how they can regain control of their personal information.

“These penalties and other orders should serve as an important reminder to all businesses that if they are not upfront with how they will use consumers’ data, they risk breaching the Australian Consumer Law,” says ACCC Chair Rod Sims.

“The ACCC is very concerned about the potential for consumer harm from the use or misuse of consumer data.”

HealthEngine also admitted that between 31 March 2015 and 1 March 2018, it did not publish around 17,000 reviews and edited around 3,000 reviews to remove negative aspects, or to embellish them.

HealthEngine also admitted that it misrepresented to consumers the reasons why it did not publish a rating for some health or medical practices.

“The ACCC was particularly concerned about HealthEngine’s misleading conduct in connection with reviews it published, because patients may have visited medical practices based on manipulated reviews that did not accurately reflect other patients’ experiences,” says Mr Sims.

HealthEngine admitted liability and made joint submissions with the ACCC to the Federal Court. It will also pay a contribution to the ACCC’s legal costs.

Must Read

New regional roadmaps for prioritising antimicrobial resistance

0
A new publication by the International Pharmaceutical Federation (FIP) identifies priority actions pharmacists should take to minimise antimicrobial resistance (AMR). The publication presents six...